H Pogglitsch, W Petek, O Wawschinek, W Holzer. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Aluminum/adverse effectsAluminum/metabolismApraxias/chemically inducedApraxias/therapyBrain Diseases/chemically inducedBrain Diseases/therapyDeferoxamine/administration & dosageDeferoxamine/metabolismDysarthria/chemically inducedDysarthria/therapyHumansMaleRenal Dialysis/adverse effects
Substances: See more » AluminumDeferoxamine
Year: 1981 PMID: 6118738 DOI: 10.1016/s0140-6736(81)91363-5
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321